Related Experiment Video
Updated: Feb 16, 2026
08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.5K
Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer
Todd A Pezzi1, David L Schwartz1,2, Abdallah S R Mohamed1,3
1Division of Radiation of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston.
JAMA Oncology
|January 6, 2018
Summary
Many patients with limited-stage small cell lung cancer (SCLC) do not receive chemotherapy and radiation therapy, impacting survival. Insurance status significantly affects treatment delivery and outcomes in SCLC care.
Area of Science:
- Oncology
- Public Health
- Health Services Research
Background:
- Combined-modality therapy (chemotherapy and radiation therapy) is vital for limited-stage small cell lung cancer (SCLC).
- Barriers to accessing these crucial treatments in the United States are not fully understood.
Purpose of the Study:
- To determine the utilization rates of chemotherapy and radiation therapy for limited-stage SCLC.
- To identify clinical and socioeconomic factors influencing treatment delivery and patient survival.
Main Methods:
- Analysis of 70,247 limited-stage SCLC cases from the National Cancer Database (2004-2013).
- Multivariable analysis to assess factors associated with treatment utilization and overall survival.
Main Results:
- Only 55.5% of patients received both chemotherapy and radiation therapy.
- Lack of insurance was linked to lower odds of receiving chemotherapy and radiation therapy.
- Government insurance (Medicaid/Medicare) was associated with lower radiation therapy use.
- Uninsured or government-insured patients had significantly shorter survival times.
- Chemotherapy and radiation therapy were associated with improved survival.
Conclusions:
- A significant portion of limited-stage SCLC patients did not receive guideline-recommended therapy, correlating with poorer survival.
- Insurance status, particularly government coverage, presents a barrier to radiation therapy delivery.
- Targeted interventions are needed to improve equitable access to SCLC treatment.
Related Concept Videos
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:27Limiting Reactant
70.7K
The relative amounts of reactants and products represented in a balanced chemical equation are often referred to as stoichiometric amounts. However, in reality, the reactants are not always present in the stoichiometric amounts indicated by the balanced equation.
70.7K
01:15Sensory Modalities
4.0K
Sensation typically is the process by which the sensory receptors and sense organs detect stimuli from the internal and external environment and transmit this information to the central nervous system for processing.
General senses refer to the broad category of sensory information detected by receptors in the body and can be further grouped into somatic and visceral senses. Somatic sensations include touch, pressure, temperature, and pain and are essential for navigating our environment and...
General senses refer to the broad category of sensory information detected by receptors in the body and can be further grouped into somatic and visceral senses. Somatic sensations include touch, pressure, temperature, and pain and are essential for navigating our environment and...
4.0K
01:47Lung Capacity
56.5K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.5K